Skip to content

Clinical trials

Phase 3 Leukemia trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Finland Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20121
20141
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ariad Pharmaceuticals1
European Organisation for Research and Treatment of Cancer - EORTC1
Mats Heyman1
Maxim Pharmaceuticals1
Nordic Society for Pediatric Hematology and Oncology1
Novartis Pharmaceuticals1
Pfizer1
Vastra Gotaland Region1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia8
Bone Marrow Diseases3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Hematologic Diseases2
Leukemia, Myeloid, Acute2
Neoplasms2
Neoplasms by Histologic Type2
Blast Crisis1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.